Previous close | 8.50 |
Open | 8.50 |
Bid | 1.50 |
Ask | 6.50 |
Strike | 185.00 |
Expiry date | 2024-01-19 |
Day's range | 8.50 - 8.50 |
Contract range | N/A |
Volume | |
Open interest | 7 |
Negative foreign exchange impact and consumables inventory deleveraging are expected to have affected Illumina's (ILMN) top line during the fourth quarter.
CVS Health's (CVS) digital capabilities are expected to have driven consumer engagement across all CVS Health businesses in Q4.
Zimmer Biomet (ZBH) is expected to have witnessed continued recovery in its legacy business in the fourth quarter, despite the choppy market situation.